ESMO 2023: Expert Perspectives & Insights into the Testing and Treatment of Melanoma - Episode 11
Treatment Approaches For Patients With BRAF-Mutated Melanoma and Asymptomatic Brain Metastases
For patients with BRAF-mutated melanoma with asymptomatic brain metastases, immunotherapy, particularly the combination of ipilimumab and nivolumab, is the preferred treatment option due to its effectiveness and durability, as supported by the seven-year follow-up data from the CHECKMATE 204 trial.
